Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Development of Parkinson's disease in patients with Narcolepsy.
Christine CW, Marks WJ Jr, Ostrem JL.
J Neural Transm. 2012 Jun;119(6):697-9. Epub 2012 Jan 10.
Related citations
Changes of hand preference in Parkinson's disease.
Stochl J, Croudace TJ, Brožová H, Klempíř J, Roth J, Růžička E.
J Neural Transm. 2012 Jun;119(6):693-6. Epub 2012 Jan 10.
Neuropsychology, neuroimaging or motor phenotype in diagnosis of Parkinson's disease-dementia: which matters most?
Di Biasio F, Vanacore N, Fasano A, Modugno N, Gandolfi B, Lena F, Grillea G, Pietracupa S, Caranci G, Ruggieri S.
J Neural Transm. 2012 May;119(5):597-604. Epub 2011 Dec 13.
CSF biomarkers in different phenotypes of Parkinson disease.
Jellinger KA.
J Neural Transm. 2012 Apr;119(4):455-6. Epub 2011 Nov 8.
Occurrence and distribution of salsolinol-like compound, 1-acetyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (ADTIQ) in Parkinsonian brains.
Deng Y, Zhang Y, Li Y, Xiao S, Song D, Qing H, Li Q, Rajput AH.
J Neural Transm. 2012 Apr;119(4):435-41. Epub 2011 Nov 8.
The default mode network integrity in patients with Parkinson's disease is levodopa equivalent dose-dependent.
Krajcovicova L, Mikl M, Marecek R, Rektorova I.
J Neural Transm. 2012 Apr;119(4):443-54. Epub 2011 Oct 15.
Pedunculopontine stimulation from primate to patient.
Pereira EA, Nandi D, Jenkinson N, Stein JF, Green AL, Aziz TZ.
J Neural Transm. 2011 Oct;118(10):1453-60. Epub 2011 Mar 30. Review.
The pedunculopontine nucleus as a target for deep brain stimulation.
Hamani C, Moro E, Lozano AM.
J Neural Transm. 2011 Oct;118(10):1461-8. Epub 2010 Dec 31. Review.
Commentary: the pedunculopontine nucleus: clinical experience, basic questions and future directions.
Mazzone P, Scarnati E, Garcia-Rill E.
J Neural Transm. 2011 Oct;118(10):1391-6. Epub 2010 Dec 25.
Heterogenous mechanisms of mild cognitive impairment in Parkinson's disease.
Jellinger K.
J Neural Transm. 2012 Mar;119(3):381-2. Epub 2011 Sep 30.
Effects of unilateral pedunculopontine stimulation on electromyographic activation patterns during gait in individual patients with Parkinson's disease.
Caliandro P, Insola A, Scarnati E, Padua L, Russo G, Granieri E, Mazzone P.
J Neural Transm. 2011 Oct;118(10):1477-86. Epub 2011 Sep 9.
The pedunculopontine nucleus: from basic neuroscience to translational applications for Parkinson's disease.
[No authors listed]
J Neural Transm. 2011 Oct;118(10):1389-90. No abstract available.
Tau protein and beta-amyloid(1-42) CSF levels in different phenotypes of Parkinson's disease.
Přikrylová Vranová H, Mareš J, Hluštík P, Nevrlý M, Stejskal D, Zapletalová J, Obereigneru R, Kaňovský P.
J Neural Transm. 2012 Mar;119(3):353-62. Epub 2011 Sep 4.
Continuous drug delivery in early- and late-stage Parkinson's disease as a strategy for avoiding dyskinesia induction and expression.
Jenner P, McCreary AC, Scheller DK.
J Neural Transm. 2011 Dec;118(12):1691-702. Epub 2011 Sep 1. Review.
Brain tissue echogenicity--implications for substantia nigra studies in parkinsonian patients.
Sadowski K, Szlachta K, Serafin-Król M, Gałązka-Friedman J, Friedman A.
J Neural Transm. 2012 Mar;119(3):363-7. Epub 2011 Sep 1.
Kynurenines in Parkinson's disease: therapeutic perspectives.
Zádori D, Klivényi P, Toldi J, Fülöp F, Vécsei L.
J Neural Transm. 2012 Feb;119(2):275-83. Epub 2011 Aug 20.
Comment: should we diagnose MCI in Parkinson disease?
Korczyn AD.
J Neural Transm. 2011 Aug;118(8):1177. Review. No abstract available.
Does WOQ-9 help to recognize symptoms of non-motor wearing-off in Parkinson's disease?
Bareš M, Rektorová I, Jech R, Farníková K, Roth J, Růžička E, Kaňovský P, Rektor I, Pavlík T, Uhlířová L, Vydlák J.
J Neural Transm. 2012 Mar;119(3):373-80. Epub 2011 Jul 17.
Biomarker candidates of neurodegeneration in Parkinson's disease for the evaluation of disease-modifying therapeutics.
Gerlach M, Maetzler W, Broich K, Hampel H, Rems L, Reum T, Riederer P, Stöffler A, Streffer J, Berg D.
J Neural Transm. 2012 Jan;119(1):39-52. Epub 2011 Jul 14. Review.
Evidence for angiogenesis in Parkinson's disease, incidental Lewy body disease, and progressive supranuclear palsy.
Desai Bradaric B, Patel A, Schneider JA, Carvey PM, Hendey B.
J Neural Transm. 2012 Jan;119(1):59-71. Epub 2011 Jul 12.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on